Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: A randomized controlled clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

1089

Figures (1-2)

111

Tables (1-6)

136

Sum=1695

Feb 28, 2006 (publication date) through Apr 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 28, 2006; 12(8): 1265-1269
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1265

Table 3 The logistic multiple regression model

Variable	Odds ratio	95%CI	P-value
HCV RNA (kcopy/mL)
<500	1.000	0.014-0.690	0.0197
≥500	0.097
Body weight (kg)
<64	1.000	0.931-63.301	0.0583
≥64	7.677
Pre-treatment platelet count (×10⁴/μL)
<16	1.000	0.032-1.909	0.1798
≥16	0.246

CI: confidence interval

Citation: Suzuki H, Takagi H, Sohara N, Kanda D, Kakizaki S, Sato K, Mori M. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: A randomized controlled clinical trial. World J Gastroenterol 2006; 12(8): 1265-1269
URL: https://www.wjgnet.com/1007-9327/full/v12/i8/1265.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i8.1265